Enter the weight to calculate the suggested starting dose for your insulin-naive patients starting Lantus®Please enter a weight between 110 lb and 505 lb
Invalid NumberPlease enter a weight between 110 lbs and 505 lbs
Initiating Lantus® in insulin-naive and switched patients
Patients with T2DM: Lantus® dosing
The recommended starting dose of Lantus® in patients with type 2 diabetes who are not currently treated with insulin is 0.2 Units/kg or up to 10 Units once daily, adjusted to patient’s appropriate FPG target. One may need to adjust the amount and timing of short- or
rapid-acting insulins and dosages of any oral anti-diabetic drugs
Patients with T1DM: Start Lantus® at an appropriate dose for each patient
The recommended starting dose of Lantus® should be approximately 1/3 of the total daily insulin requirements
Lantus® must be used with a short-acting insulin
Other dosing information
Individualize and adjust the dosage of Lantus® based on the individual’s metabolic needs, blood glucose monitoring results, and glycemic control goal
Administer Lantus® subcutaneously once a day at any time of the day, but at the same time every day
Converting from other insulin therapies may require adjustment of timing and dose of Lantus®
Closely monitor glucose values, especially upon converting to Lantus® and during the initial weeks thereafter
Dosage adjustments may be needed with changes in physical activity, changes in meal patterns, during acute illness, or changes in renal or hepatic function
Lantus® Savings OffersCommercially insured patients pay as low as $0 and no more than $99* for a 30-day supply. For patients without insurance there is an offer too. Terms and Eligibility Restrictions Apply.See Below*SEE OFFERS
*Eligibility Restrictions & Offer Terms:
Insulins Valyou Savings Program: Sanofi insulins included in this program are: ADMELOG® (insulin lispro injection) 100 Units/mL, TOUJEO® (insulin glargine injection) 300 Units/mL, LANTUS® (insulin glargine injection) 100 Units/mL and APIDRA® (insulin glulisine injection) 100 Units/mL.
This offer is not valid for prescriptions covered by or submitted for reimbursement under Medicare, Medicaid, VA, DOD, TRICARE, similar federal or state programs, including any state pharmaceutical programs, or commercial / private insurance. Only people without prescription medication insurance can apply for this offer. Void where prohibited by law. For the duration of the program, eligible patients will pay $99 for up to 10 vials or packs of pens per fill. Offer valid for one fill per month. To pay $99 per month, you must fill all your Sanofi Insulin prescriptions at the same time, together each month. Not valid for SOLIQUA 100/33 (insulin glargine and lixisenatide injection) 100 Units/mL and 33 mcg/mL or Toujeo Max SoloStar pen. When using the Insulins Valyou Savings Card, prices are guaranteed for 12 consecutive monthly fills. The Insulins Valyou Savings Program applies to the cost of medication. There are other relevant costs associated with overall treatment
Sanofi Copay Program:
This offer is not valid for prescriptions covered by or submitted for reimbursement under Medicare, Medicaid, VA, DOD, TRICARE, or similar federal or state programs including any state pharmaceutical assistance program. If you have an Affordable Care (Health Care Exchange) plan, you may still be qualified to receive and use this savings card. Please note: the Federal Employees Health Benefits (FEHB) Program is not a federal or state government health care program for purposes of the savings program. Void where prohibited by law.
Lantus: pay as low as $0 up to $99 for a 30-day supply, depending on insurance coverage. Maximum savings apply. Valid up to 10 packs per fill; Offer valid for one fill per month per 30-day supply
Savings may vary depending on patients' out-of-pocket costs. Upon registration, patients receive all program details. Sanofi US reserves the right to change the maximum cap amount, rescind, revoke or amend these programs without notice.
Lantus® Prescribing Information.
All registered trademarks cited are property of their respective owners.